NO20065536L - Behandling av astma hos barn - Google Patents

Behandling av astma hos barn

Info

Publication number
NO20065536L
NO20065536L NO20065536A NO20065536A NO20065536L NO 20065536 L NO20065536 L NO 20065536L NO 20065536 A NO20065536 A NO 20065536A NO 20065536 A NO20065536 A NO 20065536A NO 20065536 L NO20065536 L NO 20065536L
Authority
NO
Norway
Prior art keywords
asthma
children
treatment
glycopyrrolate
analog
Prior art date
Application number
NO20065536A
Other languages
English (en)
Inventor
Susan Snape
Robin Mark Bannister
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20065536L publication Critical patent/NO20065536L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Glykopyrrolat eller en analog derav er anvendelig for behandling av astma hos barn.
NO20065536A 2004-05-10 2006-11-30 Behandling av astma hos barn NO20065536L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0410399.0A GB0410399D0 (en) 2004-05-10 2004-05-10 The treatment of respiratory disease
PCT/GB2005/001791 WO2005107873A2 (en) 2004-05-10 2005-05-10 Glycopyrrolate for treating childhood asthma

Publications (1)

Publication Number Publication Date
NO20065536L true NO20065536L (no) 2006-12-08

Family

ID=32526760

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065536A NO20065536L (no) 2004-05-10 2006-11-30 Behandling av astma hos barn

Country Status (15)

Country Link
US (1) US20070243260A1 (no)
EP (1) EP1750807A2 (no)
JP (1) JP2007536362A (no)
KR (1) KR20070042917A (no)
CN (1) CN1972730A (no)
AU (1) AU2005240406A1 (no)
BR (1) BRPI0510946A (no)
CA (1) CA2565170A1 (no)
GB (1) GB0410399D0 (no)
IL (1) IL178816A0 (no)
MX (1) MXPA06013040A (no)
NO (1) NO20065536L (no)
NZ (1) NZ550909A (no)
WO (1) WO2005107873A2 (no)
ZA (1) ZA200610264B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0410398D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0613161D0 (en) 2006-06-30 2006-08-09 Novartis Ag Organic Compounds
KR101442069B1 (ko) * 2009-09-30 2014-09-18 가부시키가이샤 상기 난용성 물질의 수용해성 개선방법
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
WO2011076841A2 (en) 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Combination therapy for copd
SG181870A1 (en) 2009-12-23 2012-07-30 Chiesi Farma Spa Aerosol formulation for copd
HRP20140582T4 (hr) 2009-12-23 2023-06-09 Chiesi Farmaceutici S.P.A. Kombinacijska terapija za copd
RU2567040C2 (ru) 2009-12-23 2015-10-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Аэрозольная препаративная форма для лечения по поводу хронического обструктивного легочного заболевания
JO3510B1 (ar) 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
CN104363910A (zh) * 2012-03-14 2015-02-18 日本株式会社Ltt生物医药 慢性阻塞性肺疾病改善剂
WO2014062143A2 (en) * 2012-10-19 2014-04-24 Mahmut Bilgic Anticholinergic agent combinations
WO2014077787A1 (en) * 2012-11-16 2014-05-22 Mahmut Bilgic Combinations including abeta2 agonist and glycopyrrolate
AU2014375301C1 (en) 2013-12-30 2026-02-19 Chiesi Farmaceutici S.P.A. Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
HRP20260435T1 (hr) 2014-09-09 2026-05-08 Vectura Limited Formulacija koja sadrži glikopirolat, postupak i uređaj
JP6942126B2 (ja) * 2015-11-16 2021-09-29 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 抗コリン作用薬、コルチコステロイド及びβ−アドレナリン作用薬を含む乾燥粉末製剤の製造方法
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
PH12022551243A1 (en) 2019-12-02 2023-09-11 Chiesi Farm Spa Stainles steel can for pressurised metered dose inhalers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1150895C (zh) * 1998-11-13 2004-05-26 杰格研究股份公司 用于吸入给药的干粉
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
NZ526059A (en) * 2000-11-30 2005-05-27 Vectura Ltd Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition

Also Published As

Publication number Publication date
NZ550909A (en) 2011-02-25
ZA200610264B (en) 2008-06-25
JP2007536362A (ja) 2007-12-13
GB0410399D0 (en) 2004-06-16
CA2565170A1 (en) 2005-11-17
WO2005107873A3 (en) 2006-03-16
IL178816A0 (en) 2007-05-15
EP1750807A2 (en) 2007-02-14
KR20070042917A (ko) 2007-04-24
AU2005240406A1 (en) 2005-11-17
WO2005107873A2 (en) 2005-11-17
MXPA06013040A (es) 2007-02-12
CN1972730A (zh) 2007-05-30
BRPI0510946A (pt) 2007-11-20
US20070243260A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
DE602004020793D1 (de) 5-phenyl-4-methyl-thiazol-2-yl-amin-derivate als inhibitoren von phosphatidylinositol-3-kinase-enzymen (pi3) zur behandlung entzündlicher erkrankungen der luftwege
AT9566U3 (de) Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken
SI1827441T1 (sl) Kombinacije za zdravljenje bolezni, povezanih s celično proliferacijo
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
EP1755661A4 (en) USE OF GELSOLIN FOR THE TREATMENT OF INFECTIONS
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DOP2009000134A (es) Compuestos bicíclicos y su uso como anti-diabéticos
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
ATE517896T1 (de) P38-kinase-inhibitoren
DE602004024037D1 (de) Substituierte heterozyklen
BRPI0510946A (pt) tratamento de asma em crianças
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
NO20075368L (no) Antiinflammatoriske modaliteter
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
PL1692102T3 (pl) Kompozycje i sposoby do wykrywania i leczenia chorób i stanów związanych z receptorami chemokiny
BRPI0510947A (pt) tratamento de doença respiratória
NO20082425L (no) Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer
DE602005023452D1 (de) Mit calcitriol und clobetasolpropionat zur behandlung von schuppenflechte
ATE512968T1 (de) 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole
CL2009000250A1 (es) Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis.
CY1116166T1 (el) Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
WO2006109301A3 (en) Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application